BioCryst Pharmaceuticals Shares Outstanding 2006-2020 | BCRX

BioCryst Pharmaceuticals shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
BioCryst Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2020 167
2019 116
2018 103
2017 84
2016 74
2015 73
2014 67
2013 55
2012 49
2011 45
2010 45
2009 39
2008 38
2007 33
2006 29
2005 26
BioCryst Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2020-12-31 167
2020-09-30 177
2020-06-30 162
2020-03-31 154
2019-12-31 116
2019-09-30 110
2019-06-30 110
2019-03-31 110
2018-12-31 103
2018-09-30 105
2018-06-30 99
2018-03-31 99
2017-12-31 84
2017-09-30 84
2017-06-30 80
2017-03-31 75
2016-12-31 74
2016-09-30 74
2016-06-30 74
2016-03-31 74
2015-12-31 73
2015-09-30 73
2015-06-30 77
2015-03-31 72
2014-12-31 67
2014-09-30 72
2014-06-30 64
2014-03-31 60
2013-12-31 55
2013-09-30 57
2013-06-30 53
2013-03-31 51
2012-12-31 49
2012-09-30 51
2012-06-30 49
2012-03-31 47
2011-12-31 45
2011-09-30 45
2011-06-30 45
2011-03-31 45
2010-12-31 45
2010-09-30 45
2010-06-30 45
2010-03-31 44
2009-12-31 39
2009-09-30 38
2009-06-30 38
2009-03-31 38
2008-12-31 38
2008-09-30 38
2008-06-30 38
2008-03-31 38
2007-12-31 33
2007-09-30 34
2007-06-30 29
2007-03-31 29
2006-12-31 29
2006-09-30 29
2006-06-30 29
2006-03-31 29
2005-12-31 26
2005-09-30 26
2005-06-30 26
2005-03-31 24
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.846B $0.018B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.998B 41.56
Takeda Pharmaceutical (TAK) Japan $53.754B 9.86
Astellas Pharma (ALPMY) Japan $27.554B 17.01
Eisai (ESALY) Japan $19.671B 21.82
Catalent (CTLT) United States $18.286B 48.39
Grifols, S.A (GRFS) Spain $12.156B 14.14
Jazz Pharmaceuticals (JAZZ) Ireland $9.065B 15.14
United Therapeutics (UTHR) United States $8.941B 17.36
Neurocrine Biosciences (NBIX) United States $8.708B 20.19
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.754B 0.00
IPSEN SA ADR (IPSEY) France $7.677B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.613B 0.00
Evotec AG (EVTCY) Germany $6.224B 420.28
Ionis Pharmaceuticals (IONS) United States $6.013B 0.00
Orion OYJ (ORINY) Finland $5.789B 20.11
Sage Therapeutics (SAGE) United States $4.504B 0.00
Turning Point Therapeutics (TPTX) United States $4.019B 0.00
Hypermarcas (HYPMY) Brazil $3.845B 15.18
Nektar Therapeutics (NKTR) United States $3.507B 0.00
ChemoCentryx (CCXI) United States $3.426B 0.00
Tilray (TLRY) Canada $3.396B 0.00
PTC Therapeutics (PTCT) United States $3.394B 0.00
Revolution Medicines (RVMD) United States $3.304B 0.00
Relay Therapeutics (RLAY) United States $3.196B 0.00
Cronos Group (CRON) Canada $3.167B 0.00
Pacira BioSciences (PCRX) United States $3.005B 50.74
Taro Pharmaceutical Industries (TARO) Israel $2.792B 17.29
Organogenesis Holdings (ORGO) United States $2.781B 167.15
Corcept Therapeutics (CORT) United States $2.688B 26.95
Xencor (XNCR) United States $2.413B 0.00
USANA Health Sciences (USNA) United States $2.050B 16.97
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.835B 11.77
FibroGen (FGEN) United States $1.722B 0.00
Sundial Growers (SNDL) Canada $1.677B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.664B 13.09
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.652B 0.00
AlloVir (ALVR) United States $1.589B 0.00
Heron Therapeutics (HRTX) United States $1.578B 0.00
ImmunoGen (IMGN) United States $1.568B 0.00
Aclaris Therapeutics (ACRS) United States $1.507B 0.00
Endo (ENDP) Ireland $1.444B 2.18
Theravance Biopharma (TBPH) Cayman Islands $1.420B 0.00
Indivior (INVVY) United States $1.380B 0.00
Ocular Therapeutix (OCUL) United States $1.273B 0.00
Translate Bio (TBIO) United States $1.270B 0.00
Trillium Therapeutics (TRIL) Canada $1.152B 0.00
Zogenix (ZGNX) United States $1.084B 0.00
4D Molecular Therapeutics (FDMT) $1.083B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.995B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.932B 0.00
Aerie Pharmaceuticals (AERI) United States $0.890B 0.00
Vectura Group (VEGPF) United Kingdom $0.864B 0.00
Collegium Pharmaceutical (COLL) United States $0.811B 30.30
Bioventus (BVS) United States $0.794B 0.00
Esperion Therapeutics (ESPR) United States $0.789B 0.00
Ardelyx (ARDX) United States $0.776B 0.00
Karyopharm Therapeutics (KPTI) United States $0.761B 0.00
Harpoon Therapeutics (HARP) United States $0.733B 0.00
Silence Therapeutics (SLN) United Kingdom $0.689B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.687B 0.00
VAXART, INC (VXRT) United States $0.668B 0.00
Rafael Holdings (RFL) United States $0.665B 0.00
KalVista Pharmaceuticals (KALV) United States $0.635B 0.00
Chinook Therapeutics (KDNY) United States $0.609B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.591B 0.00
Sigilon Therapeutics (SGTX) $0.569B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.565B 0.00
Nanobiotix S.A (NBTX) $0.551B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.549B 0.00
Siga Technologies (SIGA) United States $0.542B 9.05
TherapeuticsMD (TXMD) United States $0.531B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.513B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.490B 0.00
Altimmune (ALT) United States $0.487B 0.00
Akebia Therapeutics (AKBA) United States $0.485B 0.00
Jounce Therapeutics (JNCE) United States $0.473B 0.00
Oncternal Therapeutics (ONCT) United States $0.461B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.460B 10.81
Molecular Templates (MTEM) United States $0.460B 0.00
AVITA Medical (RCEL) United States $0.455B 0.00
Summit Therapeutics (SMMT) United States $0.451B 0.00
Foghorn Therapeutics (FHTX) United States $0.438B 0.00
DURECT (DRRX) United States $0.427B 0.00
Flexion Therapeutics (FLXN) United States $0.414B 0.00
PROFOUND MEDICL (PROF) Canada $0.400B 0.00
Nature's Sunshine Products (NATR) United States $0.396B 18.87
MEI Pharma (MEIP) United States $0.374B 0.00
Acutus Medical (AFIB) United States $0.373B 0.00
Innate Pharma SA (IPHYF) France $0.347B 0.00
VYNE Therapeutics (VYNE) United States $0.327B 0.00
Redhill Biopharma (RDHL) Israel $0.311B 0.00
Infinity Pharmaceuticals (INFI) United States $0.307B 0.00
KemPharm (KMPH) United States $0.289B 0.00
CASI Pharmaceuticals (CASI) United States $0.287B 0.00
Iterum Therapeutics (ITRM) Ireland $0.284B 0.00
Alpine Immune Sciences (ALPN) United States $0.267B 0.00
Xeris Pharmaceuticals (XERS) United States $0.255B 0.00
Progenity (PROG) United States $0.245B 0.00
Taiwan Liposome (TLC) Taiwan $0.244B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.236B 0.00
Jaguar Animal Health (JAGX) United States $0.229B 0.00
Inotiv (NOTV) United States $0.226B 0.00
Novan (NOVN) United States $0.224B 0.00
Sierra Oncology (SRRA) Canada $0.211B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.208B 0.00
Lannett Co Inc (LCI) United States $0.208B 6.99
Onconova Therapeutics (ONTX) United States $0.200B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.196B 0.00
IMV INC (IMV) Canada $0.193B 0.00
CTI BioPharma (CTIC) United States $0.192B 0.00
Heat Biologics (HTBX) United States $0.186B 0.00
OptiNose (OPTN) United States $0.184B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.179B 0.00
Calithera Biosciences (CALA) United States $0.177B 0.00
SCYNEXIS (SCYX) United States $0.174B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.174B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.172B 0.00
Qilian Holding Group (QLI) China $0.168B 0.00
Vivos Therapeutics (VVOS) $0.167B 0.00
Adherex Technologies (FENC) United States $0.167B 0.00
Aquestive Therapeutics (AQST) United States $0.164B 0.00
GlycoMimetics (GLYC) United States $0.160B 0.00
IsoRay (ISR) United States $0.153B 0.00
Champions Oncology (CSBR) United States $0.152B 0.00
Concert Pharmaceuticals (CNCE) United States $0.148B 0.00
MediWound (MDWD) Israel $0.147B 0.00
Genocea Biosciences (GNCA) United States $0.144B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.144B 0.00
Nutriband (NTRB) United States $0.140B 0.00
Lipocine (LPCN) United States $0.139B 0.00
Aziyo Biologics (AZYO) United States $0.135B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.127B 0.00
Minerva Neurosciences (NERV) United States $0.117B 45.67
La Jolla Pharmaceutical (LJPC) United States $0.115B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.111B 0.00
Savara (SVRA) United States $0.111B 0.00
AIM ImmunoTech (AIM) United States $0.109B 0.00
Regulus Therapeutics (RGLS) United States $0.108B 0.00
Otonomy (OTIC) United States $0.106B 0.00
Natural Alternatives (NAII) United States $0.103B 27.93
Assertio Holdings (ASRT) United States $0.102B 0.00
Recro Pharma (REPH) United States $0.100B 0.00
ElectroCore (ECOR) United States $0.100B 0.00
Baudax Bio (BXRX) United States $0.088B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.086B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.083B 0.00
ProPhase Labs (PRPH) United States $0.081B 0.00
India Globalization Capital (IGC) United States $0.079B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.077B 0.00
Brickell Biotech (BBI) United States $0.073B 0.00
Addex Therapeutics (ADXN) Switzerland $0.069B 0.00
Sigyn Therapeutics (SIGY) United States $0.067B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.064B 0.00
Biomerica (BMRA) United States $0.063B 0.00
AgeX Therapeutics (AGE) United States $0.062B 0.00
PolarityTE (PTE) United States $0.060B 0.00
Inhibikase Therapeutics (IKT) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.055B 0.00
CV Sciences (CVSI) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 66.00
Opiant Pharmaceuticals (OPNT) United States $0.046B 0.00
Viracta Therapeutics (VIRX) United States $0.045B 0.00
Mannatech (MTEX) United States $0.042B 7.46
Can-Fite Biopharma (CANF) Israel $0.041B 0.00
RXi Pharmaceuticals (PHIO) United States $0.037B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.037B 0.00
4D Pharma (LBPS) United Kingdom $0.035B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.033B 0.00
Petros Pharmaceuticals (PTPI) United States $0.031B 0.00
Midatech Pharma (MTP) United Kingdom $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
JanOne (JAN) United States $0.022B 0.00
Plus Therapeutics (PSTV) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.021B 17.00
Bellicum Pharmaceuticals (BLCM) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
SHINECO INC (TYHT) China $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00